353 related articles for article (PubMed ID: 22000655)
21. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome.
Min SI; Yun IJ; Kang JM; Park YJ; Min SK; Ahn C; Kim SJ; Ha J
Nephrol Dial Transplant; 2009 Aug; 24(8):2584-90. PubMed ID: 19395726
[TBL] [Abstract][Full Text] [Related]
22. Frequency of hyperuricemia and effect of calcineurin inhibitors on serum uric acid levels in liver transplanted children.
Tumgor G; Arikan C; Kilic M; Aydogdu S
Pediatr Transplant; 2006 Sep; 10(6):665-8. PubMed ID: 16911488
[TBL] [Abstract][Full Text] [Related]
23. Hyperuricemia in pediatric renal transplant recipients.
Uslu Gokceoglu A; Akman S; Koyun M; Comak E; Dogan CS; Akbas H; Dinckan A
Exp Clin Transplant; 2013 Dec; 11(6):489-93. PubMed ID: 24344940
[TBL] [Abstract][Full Text] [Related]
24. Serum uric acid is independently associated with metabolic syndrome in subjects with and without a low estimated glomerular filtration rate.
See LC; Kuo CF; Chuang FH; Li HY; Chen YM; Chen HW; Yu KH
J Rheumatol; 2009 Aug; 36(8):1691-8. PubMed ID: 19531754
[TBL] [Abstract][Full Text] [Related]
25. The association between serum uric acid levels at 3 months after renal transplantation and the graft outcome in living donor renal transplantation.
Choi JY; Kwon OJ
Transplant Proc; 2013 May; 45(4):1548-52. PubMed ID: 23726617
[TBL] [Abstract][Full Text] [Related]
26. Uric acid--a uremic toxin?
Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
[TBL] [Abstract][Full Text] [Related]
27. The independent association between serum uric acid and graft outcomes after kidney transplantation.
Haririan A; Nogueira JM; Zandi-Nejad K; Aiyer R; Hurley H; Cooper M; Klassen DK; Weir MR
Transplantation; 2010 Mar; 89(5):573-9. PubMed ID: 19997058
[TBL] [Abstract][Full Text] [Related]
28. Hyperuricemia after renal transplantation.
Kalantar E; Khalili N; Hossieni MS; Rostami Z; Einollahi B
Transplant Proc; 2011 Mar; 43(2):584-5. PubMed ID: 21440768
[TBL] [Abstract][Full Text] [Related]
29. Hyperuricemia in kidney transplant recipients with intact graft function.
Kim KM; Kim SS; Han DJ; Yang WS; Park JS; Park SK
Transplant Proc; 2010 Nov; 42(9):3562-7. PubMed ID: 21094816
[TBL] [Abstract][Full Text] [Related]
30. Renal Effects of Hyperuricemia.
Méndez Landa CE
Contrib Nephrol; 2018; 192():8-16. PubMed ID: 29393089
[TBL] [Abstract][Full Text] [Related]
31. Does asymptomatic hyperuricaemia contribute to the development of renal and cardiovascular disease? An old controversy renewed.
Kanellis J; Feig DI; Johnson RJ
Nephrology (Carlton); 2004 Dec; 9(6):394-9. PubMed ID: 15663643
[TBL] [Abstract][Full Text] [Related]
32. J-shaped mortality relationship for uric acid in CKD.
Suliman ME; Johnson RJ; García-López E; Qureshi AR; Molinaei H; Carrero JJ; Heimbürger O; Bárány P; Axelsson J; Lindholm B; Stenvinkel P
Am J Kidney Dis; 2006 Nov; 48(5):761-71. PubMed ID: 17059995
[TBL] [Abstract][Full Text] [Related]
33. Impact of Hyperuricemia on Long-term Outcomes of Kidney Transplantation: Analysis of the FAVORIT Study.
Kalil RS; Carpenter MA; Ivanova A; Gravens-Mueller L; John AA; Weir MR; Pesavento T; Bostom AG; Pfeffer MA; Hunsicker LG
Am J Kidney Dis; 2017 Dec; 70(6):762-769. PubMed ID: 28801121
[TBL] [Abstract][Full Text] [Related]
34. Uric acid: bystander or culprit in hypertension and progressive renal disease?
Menè P; Punzo G
J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
[TBL] [Abstract][Full Text] [Related]
35. The role of hyperuricemia in vascular disorders.
Edwards NL
Curr Opin Rheumatol; 2009 Mar; 21(2):132-7. PubMed ID: 19339923
[TBL] [Abstract][Full Text] [Related]
36. Hypertension was the major risk factor leading to development of cardiovascular diseases among men with hyperuricemia.
Lin KC; Tsao HM; Chen CH; Chou P
J Rheumatol; 2004 Jun; 31(6):1152-8. PubMed ID: 15170929
[TBL] [Abstract][Full Text] [Related]
37. Post-transplant Hyperuricemıa as a Cardıovascular Risk Factor.
Erkmen Uyar M; Sezer S; Bal Z; Guliyev O; Tutal E; Kulah E; Genctoy G; Ozdemir Acar N; Haberal M
Transplant Proc; 2015 May; 47(4):1146-51. PubMed ID: 26036541
[TBL] [Abstract][Full Text] [Related]
38. Hyperuricemia and chronic kidney disease: an enigma yet to be solved.
Dousdampanis P; Trigka K; Musso CG; Fourtounas C
Ren Fail; 2014 Oct; 36(9):1351-9. PubMed ID: 25112538
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of losartan in treatment of hyperuricemia and posttransplantation erythrocytosis: results of a prospective, open, randomized, case-control study.
Zhu X; Chen J; Han F; Cheng M; Xu L; Zhang L; Ding X; Le Y
Transplant Proc; 2009 Nov; 41(9):3736-42. PubMed ID: 19917377
[TBL] [Abstract][Full Text] [Related]
40. Effect of the metabolic syndrome and hyperuricemia on outcome in patients with coronary artery disease (from the Bezafibrate Infarction Prevention Study).
Brodov Y; Behar S; Boyko V; Chouraqui P
Am J Cardiol; 2010 Dec; 106(12):1717-20. PubMed ID: 21126615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
